bf/NASDAQ:AMGN_icon.jpeg

NASDAQ:AMGN

Amgen Inc.

  • Stock

$

USD

Last Close

269.41

22/09 20:00

Market Cap

143.19B

Beta: 0.63

Volume Today

1.70M

Avg: 2.66M

PE Ratio

19.86

PEG: 0.94

Dividend Yield

3.31%

Payout:64.92%

  • industry

    Drug Manufacturers / General
  • exchange

    NASDAQ Global Select
  • website

    www.amgen.com
  • ipo date

    May 01, 1987
  • full time employees

    25,200
  • currency

    USD

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory disease...Show More

Earnings

Earnings per Share (Estimate)

123452013-07-302015-07-302017-07-252019-07-302021-08-03

Revenue (Estimate)

1B2B3B4B5B6B7B2013-07-302015-07-302017-07-252019-07-302021-08-03

Revenue Breakdown

Segment Revenue
Product

24.30B

Product And Service

1.68B

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.